This edition of the Genetic TOE depicts the current landscape and the new life sciences trends across technologies empowering diagnostics.
The technology synergy observed to address current concerns in cancer diagnostics and the development of monoclonal antibodies to target Parkinson's disease are illustrated. The corresponding patent scenario is also depicted along with industry interactions.
The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Keywords: 3D bioprinting platform, targeted antibodies, Parkinson's disease, skin cancer detection, Raman spectroscopy, genetic testing